Leicester scientists seek to disarm TB's 'molecular weapon'March 06, 2008Scientists at the University of Leicester are claiming a new advance in their fight against the resurgence of TB in Britain. They have isolated the molecular 'weapons' of the bacterium and are now assessing ways to make the bacterium impotent. Scientists in the University's Department of Biochemistry are focusing on two proteins in the TB bacterium which, it is thought, allows it to thrive in white blood cells. They are particularly examining a 'long arm' in a molecule of the bacterium which is thought to be used to bind onto white blood cells. The scientists are also seeking to identify which part of the white blood cell is being targeted. Dr. Mark Carr, from the Department of Biochemistry said: "If you were to ask most people about TB, they would have most likely told you it was no longer a threat, merely a memory of a Britain with an undeveloped healthcare system. "But TB is on the rise around the world with the number of new reported cases nearly doubling in the past 25 years. The World Health Organisation reported 8,500 instances in the UK in 2005. "At the University of Leicester, our aim is to take the molecular 'weapons' of TB and isolate them, to understand their function and hopefully find a way to minimise their effects. "One of the most important of these molecular weapons is known as the ESAT-6/CFP-10 complex. These are two proteins that bind together to become a functional unit, and it is thought that they may be needed to allow the bacteria to thrive inside white blood cells, as happens during the initial infection. Removal of the genes for this complex from the TB genome renders the bacteria unable to cause disease, exposing how important this particular weapon is to the bacteria. "Similarly, studies of the structure of the protein complex have shown that removal of a 'long arm' from the molecule prevents the complex's ability to bind to the outer surface of human white blood cells. This data has provided us with a potential insight into the important components of this complex." Dr. Carr added: "Current work is attempting to identify the exact components of the human white blood cells that this complex is targeting. Once found, this should give us a greater knowledge of the action of these molecular weapons of TB and give us the edge in the war against an ancient, reawakened foe." University of Leicester |
|||||||||||||||||||||
| Related White Blood Cell Current Events and White Blood Cell News Articles Immunotherapy demonstrates long-term success in treating lymphoma Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue. New study results demonstrate high success rates using specialized white blood cells to prevent or treat lymphoma associated with the Epstein-Barr virus (EBV-lymphoma) in patients who have received a hematopoietic stem cell transplant (HSCT). Discovery of genetic defect may lead to better treatments for common gut diseases New findings related to an uncommon genetic disorder may impact the diagnosis and treatment of inflammatory bowel disease (IBD), the most common chronic gastrointestinal illness in children and teens. Two million Americans have IBD which involves inflammation of the gastrointestinal tract. Body's immune system response to dental plaque varies by gender and race Will neglecting to brush your teeth damage more than just your smile? Can failing to attack dental plaque increase your risk of heart damage? Experimental drug lets B cells live and lymphoma cells die An investigative drug deprived non-Hodgkin lymphoma cells of their ability to survive too long and multiply too fast, according to an early study published recently in the journal Experimental Hematology. Master gene that switches on disease-fighting cells identified by scientists The master gene that causes blood stem cells to turn into disease-fighting 'Natural Killer' (NK) immune cells has been identified by scientists, in a study published in Nature Immunology today. Using insects to test for drug safety Insects, such as some moths and fruit flies, react to microbial infection in the same way as mammals and so can be used to test the efficiency of new drugs, thereby reducing the need for animal testing. McGill/JGH researchers successfully reverse multiple sclerosis in animals A new experimental treatment for multiple sclerosis (MS) completely reverses the devastating autoimmune disorder in mice, and might work exactly the same way in humans, say researchers at the Jewish General Hospital Lady Davis Institute for Medical Research and McGill University in Montreal. Natural born killers -- how the body's frontline immune cells decide which cells to destroy The mechanism used by 'Natural Killer' immune cells in the human body to distinguish between diseased cells, which they are meant to destroy, and normal cells, which they are meant to leave alone, is revealed in new detail in research. Genetic Testing May Be Valuable in Treating Colorectal Cancer For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a standard treatment that has been shown to improve survival. Common allergy drug reduces obesity and diabetes in mice Crack open the latest medical textbook to the chapter on type 2, or adult-onset, diabetes, and you'll be hard pressed to find the term "immunology" anywhere. More White Blood Cell Current Events and White Blood Cell News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||